STOCK TITAN
  1. Home
  2. SEC Filings
  3. VYLR
  4. [8-K] Vylor Inc. Reports Material Event

Vylor Q3 continuing-operations loss widens to $480M

Nine-month adjusted Pro Forma Operating EBITDA and EPS rose 8% and 6%, while GAAP continuing-operations income fell 18%.

Available on EDGAR Accepted by SEC EDGAR
Filing Impact
(High)
Filing Sentiment

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

How Sentiment worksHow the balance works

Form Type
8-K

Rhea-AI Filing Summary

Vylor Inc. reported pro forma results for the third quarter and nine months ended September 30, 2026. Third-quarter net sales were $938 million, down 1% year over year, and organic sales declined 3%; volume fell 9%, partly offset by a 6% increase in price/mix. GAAP loss from continuing operations after tax was $480 million, compared with a $391 million loss a year earlier; adjusted Pro Forma Operating EBITDA was a $269 million loss, down 33%.

For the first nine months, net sales were $8.53 billion, up 4%, and organic sales were $8.41 billion, up 2%. GAAP income from continuing operations after tax was $1.01 billion, down 18%; adjusted Pro Forma Operating EBITDA was $2.66 billion, up 8%, and adjusted Pro Forma Operating EPS was $2.37 per share, up 6%. Vylor reaffirmed 2026 guidance: adjusted Pro Forma Operating EBITDA of approximately $2.8 billion and adjusted Pro Forma Operating EPS of $2.25 to $2.35 per share. Its announced capital returns include a new $3 billion multi-year share repurchase program and a $0.13 per share dividend payable December 7, 2026, to shareholders of record November 30, 2026.

2 points · 0 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

0 major · 3 points

How the balance works

Positive

  • Moderate pointNine-month adjusted Pro Forma Operating EBITDA rose 8% to $2.66 billion.
  • Moderate pointNine-month adjusted Pro Forma Operating EPS rose 6% to $2.37 per share.

Negative

  • Moderate pointThird-quarter GAAP continuing-operations loss was $480 million, 23% larger year over year.
  • Moderate pointThird-quarter adjusted Pro Forma Operating EBITDA was a $269 million loss, down 33%.
  • Moderate pointNine-month GAAP continuing-operations income fell 18% to $1.01 billion.

Filing Explained

At September 30, 2026, Vylor’s pro forma balance sheet showed $1,312 million in cash, $3,144 million in short-term borrowings, and $2,510 million in long-term debt.

This 8-K furnishes Vylor’s third-quarter results and reports that its separation from Corteva was completed on October 1, 2026, leaving Vylor operating as a standalone company.

The release says its pro forma statements are informational: they do not show what results would have been had the transactions occurred on the stated dates and do not project future results.

At September 30, 2026, the pro forma balance sheet lists $1,312 million in cash, $3,144 million in short-term borrowings, and $2,510 million in long-term debt.

On that same reported balance-sheet basis, short-term borrowings exceeded cash, with long-term debt also outstanding.

Item 2.02 Results of Operations and Financial Condition Financial
Disclosure of earnings results, typically an earnings press release or preliminary financials.
Item 9.01 Financial Statements and Exhibits Exhibits
Financial statements, pro forma financial information, or exhibit attachments filed with this report.
Third-quarter pro forma net sales $938 million Third quarter ended September 30, 2026
Third-quarter GAAP loss from continuing operations after tax $480 million loss Compared with a $391 million loss in third quarter 2025
Third-quarter adjusted Pro Forma Operating EBITDA $269 million loss Down 33% from third quarter 2025
Nine-month pro forma net sales $8.53 billion Nine months ended September 30, 2026; up 4% year over year
Nine-month GAAP income from continuing operations after tax $1.01 billion Nine months ended September 30, 2026; down 18% year over year
Nine-month adjusted Pro Forma Operating EBITDA $2.66 billion Nine months ended September 30, 2026; up 8% year over year
Nine-month adjusted Pro Forma Operating EPS $2.37 per share Nine months ended September 30, 2026; up 6% year over year
Pro Forma Organic Sales financial
"Pro Forma Organic Sales is defined as price and volume"
Adjusted Pro Forma Operating EBITDA financial
"Adjusted Pro Forma Operating EBITDA (Non-GAAP)"
A measure of a company’s recurring operating profit before interest, taxes and non-cash charges, shown as if certain events or adjustments (like acquisitions, divestitures, one-time costs or expected cost savings) had already happened. Investors use it to estimate the business’s underlying cash-generating performance and to compare companies or deal scenarios on an even footing — like judging two stores after removing one-off repairs and assuming planned remodels are complete.
Article 11 of Regulation S-X regulatory
"prepared in accordance with Article 11 of Regulation S-X"
mark-to-market activity financial
"net unrealized gain or loss from mark-to-market activity"
Third-quarter pro forma net sales $938 million Down 1% year over year
Third-quarter GAAP loss from continuing operations after tax $480 million loss 23% larger loss year over year
Third-quarter adjusted Pro Forma Operating EBITDA $269 million loss Down 33% year over year
Nine-month pro forma net sales $8.53 billion Up 4% year over year
Nine-month GAAP income from continuing operations after tax $1.01 billion Down 18% year over year
Nine-month adjusted Pro Forma Operating EBITDA $2.66 billion Up 8% year over year
Nine-month adjusted Pro Forma Operating EPS $2.37 per share Up 6% year over year
Guidance

For full-year 2026, adjusted Pro Forma Operating EBITDA is expected to be approximately $2.8 billion and adjusted Pro Forma Operating EPS is expected to be $2.25 to $2.35 per share.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is VYLR's 2026 financial guidance?
Vylor reaffirmed full-year 2026 guidance for adjusted Pro Forma Operating EBITDA of approximately $2.8 billion and adjusted Pro Forma Operating EPS of $2.25 to $2.35 per share. The company said those ranges represent growth of 10% and 5%, respectively, at the midpoint.

When is VYLR's $0.13 dividend payable?
Vylor's $0.13 per share dividend is payable December 7, 2026, to shareholders of record as of November 30, 2026.

What drove VYLR's third-quarter sales changes?
Third-quarter pro forma net sales decreased 1% year over year. Volume fell 9%, while price/mix increased 6% and currency had a favorable 2% impact.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Understanding 8-K Material Events →
See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
false000212862600021286262026-11-122026-11-12

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
FORM 8-K
 
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF
THE SECURITIES EXCHANGE ACT OF 1934
 
Date of Report (Date of Earliest Event Reported): November 11, 2026
Vylor Inc.
(Exact Name of Registrant as Specified in Its Charter)
 
Delaware001-4337641-2930124
(State or other jurisdiction(Commission(I.R.S. Employer
of Incorporation)File Number)Identification No.)
 
7100 NW 62nd Avenue,
Johnstown, Iowa 50131
(Address of principal executive offices)(Zip Code)
 
(515) 535-3200
(Registrant’s telephone number, including area code)
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
☐    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
☐    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
 
☐    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

☐    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act: 
Title of each classTrading Symbol(s)Name of each exchange on which registered
Common Stock, par value $0.01 per shareVYLRNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
 
Emerging growth company  ☐
 
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o


Item 2.02     Results of Operations and Financial Condition
On November 11, 2026, Vylor Inc. (the “Company”) announced its consolidated financial results for the quarter ended September 30, 2026. A copy of the Company’s press release and financial statement schedules are furnished herewith on Form 8-K as Exhibits 99.1 and 99.2, respectively. The information contained in this report, including Exhibits 99.1 and 99.2, is being furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section. In addition, the information contained in this report shall not be deemed to be incorporated by reference into any registration statement or other document filed by the Company under the Securities Act of 1933, as amended, or the Exchange Act except as expressly set forth by specific reference in such filing.


Item 9.01     Financial Statements and Exhibits

(d)    Exhibits.
99.1
Press Release dated November 11, 2026
99.2
Financial Statement Schedules dated November 11, 2026
104The cover page from the Company’s Current Report on Form 8-K, formatted in Inline XBRL







SIGNATURE
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
 
Vylor Inc.
(Registrant)
/s/ Colleen P. Hopper
Colleen P. Hopper
Vice President, Corporate Finance and Accounting Officer
 
November 12, 2026


1 News Release Vylor Reaffirms Full-Year Guidance on Strong YTD Results, Advances Leading Technology • Americas YTD results reflect strong demand for latest hybrids and varieties, net licensing improvement in both corn and soybeans • Rest of World YTD results reflect continued demand for top technology, partially offset by weather-related volume impacts • Full-year 2026 guidance3 supports confidence in 2029 Financial Framework announced at September 15th Investor Day • New $3 billion share repurchase program and $0.13 per share dividend reinforce commitment to long-term value creation Johnston, Iowa, November 11, 2026 – Vylor, Inc. (NYSE: VYLR) (“Vylor” or the “Company”) today reported financial results for the third quarter and nine months ended September 30, 2026. 3Q 2026 Results Overview Pro Forma Net Sales1 Pro Forma Loss from Cont. Ops (After Tax) 1 Pro Forma EPS1 GAAP $938M ($480M) ($0.72) vs. 3Q 2025 (1)% (23)% (24)% Pro Forma Organic2 Sales Adj. Pro Forma Op. EBITDA2 Adj. Pro Forma Op. EPS2 NON-GAAP $911M ($269M) ($0.42) vs. 3Q 2025 (3)% (33)% (2)% 2026 YTD Results Overview Pro Forma Net Sales1 Pro Forma Inc. from Cont. Ops (After Tax) 1 Pro Forma EPS1 GAAP $8.53B $1.01B $1.50 vs. 2025 YTD 4% (18)% (17)% Pro Forma Organic2 Sales Adj. Pro Forma Op. EBITDA2 Adj. Pro Forma Op. EPS2 NON-GAAP $8.41B $2.66B $2.37 vs. 2025 YTD 2% 8% 6% 2026 YTD Highlights • Pro forma net sales1 increased 4% versus prior year. Pro forma organic2 sales increased 2% in the same period, led by North America. • Americas pro forma net sales1 increased 4% and pro forma organic2 sales increased 3%. Price/mix was up 3% with continued execution on the Company’s price for value strategy and increased licensing income. Volumes were flat as lower corn acres in North America and the shift to a licensing model in Brazil soybeans were offset by higher soybean acres in North America and higher corn volumes in Argentina. • Rest of World pro forma net sales1 increased 4% and pro forma organic2 sales increased 1%. Volume decreased 4%, driven by reduced corn acreage in Europe and APAC due to weather, partially offset by higher sunflower acreage in Europe. Price/mix was up 5% with continued execution on the Company’s price for value strategy and increased licensing income. • GAAP pro forma income1 and earnings per share1 (EPS) from continuing operations were $1.01 billion and $1.50 per share, respectively. • Adjusted Pro Forma Operating EBITDA2 and Adjusted Pro Forma Operating EPS2 were $2.66 billion, and $2.37 per share, respectively. • The Company reiterated full-year 2026 guidance3 and expects Adjusted Pro Forma Operating EBITDA2 to be approximately $2.8 billion. Adjusted Pro Forma Operating EPS2 is expected to be $2.25 to $2.35 per share. 1. Information is presented on a pro forma basis in compliance with Article 11 of Registration S-X and giving effect to the transactions described in the Form 8-K filed with the Securities and Exchange Commission (“SEC”) on November 12, 2026. Non-GAAP measures for these periods are reconciled to the GAAP pro forma measures. 2. Pro Forma Organic Sales, Adjusted Pro Forma Operating EBITDA, Adjusted Pro Forma Operating EBITDA Margin, and Adjusted Pro Forma Operating EPS are non-GAAP financial measures. See pages 6-8 regarding forward-looking non-GAAP measures. See page A-4 for non-GAAP reconciliations. 3. The Company does not provide the most comparable GAAP measure on a forward-looking basis. See pages 7-8 for further discussion. 4. Other oilseeds includes sunflower and canola. Other product line primarily includes cotton, sorghum, wheat, rice, inoculants, and millet.

 

News Release 3Q 2026 2 "The successful completion of the separation marked an important milestone for Vylor, positioning us to move faster, sharpen our focus, and capitalize on significant opportunities ahead. It is a reflection of the tremendous work of our teams in delivering a complex transaction on time and under budget. At the same time, we remain focused on what matters most: serving customers, delivering on our commitments, and executing our strategy. Our strong year-to-date performance demonstrates the essential nature of our business, the strength of our innovation pipeline, and the benefits of disciplined operational execution. We delivered meaningful EBITDA growth and margin expansion, driven by strong demand for our industry-leading technologies, continued productivity improvements, and value-focused commercial execution. As we begin our journey as a standalone company, our third quarter performance reinforces our confidence in the 2029 financial framework we shared at Investor Day, and we remain on track to deliver our 2026 commitments." Chuck Magro Chief Executive Officer Company Updates Vylor Hosts Inaugural Investor Day On September 15, 2026, Vylor hosted its first Investor Day, highlighting the Company’s strategy, innovation pipeline, long-term growth opportunities and financial framework, with key messages including the following: • The Company is home to a $19 billion technology pipeline, anchored by 12 groundbreaking technology platform launches in corn, soybean and wheat in the next decade, including the following: o Corn Seven new corn technology platforms will be launched over the next decade – starting in 2028 – including the industry's first-ever trait designed to improve yield and yield stability. In addition, the Company is developing the industry's first gene-edited multi-disease resistant corn platform, designed to provide built-in protection against multiple major diseases, while helping farmers protect yield potential and reduce crop management complexity. o Soybeans Four new technology platforms will launch by 2035, including a proprietary, next generation technology platform for Latin America that will include the broadest spectrum of insect control on the market while also delivering strong yields for farmers and significant licensing opportunities. o Wheat Xpedite™, the system used to create Vylor's proprietary hybrid wheat, will launch in North America in 2027. Multi-year research trials demonstrate and confirm the hybrid wheat's consistently strong yields as well as its yield stability, or resilience against a variety of adverse conditions including disease and drought. • In addition, via Vylor One, its new licensing business, the Company expects to deliver approximately $500 million in gross licensing income in 2027, over $1 billion by 2035, and approach $2 billion by 2040. • The Company is targeting net sales of approximately $11.2 billion to $11.9 billion by 2029, representing 3% to 4% annual growth over the planning period, operating EBITDA of approximately $3.3 billion to $3.7 billion by 2029, and approximately 30% Operating EBITDA margins by 2029. • Finally, the Company’s disciplined capital allocation strategy is focused on balancing continued R&D investment with dividends, share repurchases and strategic M&A. o On October 22, 2026, the Company announced that its Board of Directors authorized a common stock dividend of $0.13 per share, payable December 7, 2026, to shareholders of record as of November 30, 2026, as well as a new $3 billion multi-year share repurchase program, effective immediately with no expiration date.

 

News Release 3Q 2026 3 Summary of Third Quarter 2026 For the third quarter ended September 30, 2026, pro forma net sales1 decreased 1% versus the same period last year. Pro forma organic2 sales decreased 3%. Volume decreased 9% versus prior year. Americas volume decreased 6% on the shift to a licensing model in Brazil soybeans, an earlier planting season in North America soybeans, and lower corn acreage in North America, partially offset by higher Argentina and Brazil summer corn sales. Volume decreased 16% in Rest of World primarily driven by a reduction in corn acreage due to weather. Price/mix was up 6% versus prior year, reflecting continued execution on the Company’s price for value strategy, coupled with increased licensing income. GAAP pro forma loss from continuing operations after income taxes1 was $480 million in third quarter of 2026 compared to a loss of $391 million in third quarter of 2025. Adjusted Pro Forma Operating EBITDA1,2 for the third quarter of 2026 was a loss of $269 million, down 33% compared to prior year, translating into approximately 730 basis points of Adjusted Pro Forma Operating EBITDA margin1,2 decline. 3Q 3Q % % ($ in millions, except where noted) 2026 2025 Change Organic2 Change Pro Forma Net Sales1 $938 $944 (1)% (3)% Corn $607 $586 4% (2)% Soybeans $133 $179 (26)% (26)% Other Oilseeds4 $150 $135 11% 15% Other4 $48 $44 9% 9% 2026 2025 % % ($ in millions, except where noted) YTD YTD Change Organic2 Change Pro Forma Net Sales1 $8,531 $8,235 4% 2% Corn $5,848 $5,616 4% 2% Soybeans $1,796 $1,788 - % - % Other Oilseeds4 $621 $550 13% 12% Other4 $266 $281 (5)% (4)%

 

News Release 3Q 2026 4 Americas Summary Americas pro forma net sales1 were $613 million in the third quarter of 2026, up 3% compared to the third quarter of 2025. This reflects a 7% increase in price/mix and a 2% favorable currency impact, partially offset by a 6% decrease in volume. Volume declines in the quarter reflect the shift to a licensing model in Brazil soybeans, an earlier planting season in North America soybeans, and lower corn acres in North America, partially offset by higher Argentina and Brazil summer corn sales. The increase in price is due primarily to increased licensing income and continued demand for top technology. Favorable currency impacts were led by the Brazilian Real. Adjusted pro forma segment operating EBITDA was a loss of $84 million in the third quarter of 2026, an improvement of 19% from the third quarter of 2025. Benefits from net licensing, price/mix execution and productivity more than offset lower volumes, legal fees on favorable settlement, higher IT costs, and higher freight and warehousing costs. Adjusted pro forma segment operating EBITDA margin improved by approximately 380 basis points versus the prior-year period. 3Q 3Q % % ($ in millions, except where noted) 2026 2025 Change Organic2 Change Corn $432 $382 13% 9% Soybeans $128 $172 (26)% (26)% Other Oilseeds4 $14 $16 (13)% (13)% Other4 $39 $24 63% 63% Total 3Q Americas Pro Forma Net Sales1 $613 $594 3% 1% 3Q Americas Adj. Pro Forma Segment Op. EBITDA ($84) ($104) 19% N/A Americas pro forma net sales1 were $6.76 billion for the first nine months of 2026, up 4% from the same period of 2025. The sales increase is driven by a 3% increase in price and a 1% favorable impact from currency. Volumes were flat. Price gains demonstrate continued demand for top technology coupled with increased licensing income. Volumes were flat as lower corn acres in North America and the shift to a licensing model in Brazil soybeans were offset by higher soybean acres in North America and higher corn sales in Argentina. Favorable currency impacts were led by the Brazilian Real, the Mexican Peso, and the Canadian Dollar. Adjusted pro forma segment operating EBITDA was $2.88 billion for the first nine months of 2026, up 11% from the same period of 2025. Benefits from net licensing, price/mix execution, ongoing productivity actions, and lower commodity costs more than offset higher freight and warehousing costs, legal fees on favorable settlement, and higher IT costs. Adjusted pro forma segment operating EBITDA margin improved by approximately 285 basis points versus the prior-year period. 2026 2025 % % ($ in millions, except where noted) YTD YTD Change Organic2 Change Corn $4,635 $4,428 5% 3% Soybeans $1,764 $1,755 1% - % Other Oilseeds4 $203 $186 9% 8% Other4 $158 $161 (2)% (4)% Total YTD Americas Pro Forma Net Sales1 $6,760 $6,530 4% 3% YTD Americas Adj. Pro Forma Segment Op. EBITDA $2,880 $2,597 11% N/A

 

News Release 3Q 2026 5 Rest of World Summary Rest of World pro forma net sales1 were $325 million in the third quarter of 2026, down 7% from the third quarter of 2025. This reflects a 5% increase in price/mix and a 4% favorable impact from currency, more than offset by a 16% decrease in volume. Volume declines in the quarter primarily reflect corn acreage reductions across Europe due to historic drought and in India due to delayed monsoons, partially offset by a shift to sunflower acres in France, Spain, and South Africa. The increase in price/mix demonstrates demand for top technology and increased licensing income. Favorable currency impacts were led by the South African Rand. Adjusted pro forma segment operating EBITDA was $92 million in the third quarter of 2026, down 31% from the third quarter of 2025. Price/mix execution and benefits from net licensing were more than offset by lower volumes due to weather and higher freight, duty and warehousing costs. Adjusted pro forma segment operating EBITDA margin declined by approximately 1,000 basis points versus the prior-year period. 3Q 3Q % % ($ in millions, except where noted) 2026 2025 Change Organic2 Change Corn $175 $204 (14)% (23)% Soybeans $5 $7 (29)% (29)% Other Oilseeds4 $136 $119 14% 18% Other4 $9 $20 (55)% (55)% Total 3Q Rest of World Pro Forma Net Sales1 $325 $350 (7)% (11)% 3Q Rest of World Adj. Pro Forma Segment Op. EBITDA $92 $134 (31)% N/A Rest of World pro forma net sales1 were $1.77 billion for the first nine months of 2026, up 4% from the same period of 2025. The sales increase reflects a 5% increase in price and a 3% favorable impact from currency, partially offset by a 4% decrease in volume. The increase in price/mix demonstrates demand for top technology and increased licensing income. Volume declines reflect lower corn acreage in Europe due to drought and higher fertilizer costs and in India due to delayed monsoons, partially offset by higher European sunflower acreage. Favorable currency impacts were led by the Euro, partially offset by the Turkish Lira. Adjusted pro forma segment operating EBITDA was $555 million for the first nine months of 2026, down 2% from the same period of 2025. Price/mix execution and benefits from net licensing were more than offset by lower volumes due to weather, higher freight & duty and other production costs, and higher selling expense. Adjusted pro forma segment operating EBITDA margin declined by approximately 200 basis points versus the prior-year period. 2026 2025 % % ($ in millions, except where noted) YTD YTD Change Organic2 Change Corn $1,213 $1,188 2% (3)% Soybeans $32 $33 (3)% (12)% Other Oilseeds4 $418 $364 15% 15% Other4 $108 $120 (10)% (4)% Total YTD Rest of World Pro Forma Net Sales1 $1,771 $1,705 4% 1% YTD Rest of World Adj. Pro Forma Segment Op. EBITDA $555 $568 (2)% N/A

 

News Release 3Q 2026 6 2026 Guidance The global agricultural environment remains constructive, supported by strong demand for grains and oilseeds, improved crop prices and growing demand for renewable fuels. Global consumption remains robust, while continued growth in food, feed and biofuels demand reinforces the need for agricultural productivity. At the same time, Brazil’s expanding production is helping meet rising domestic ethanol demand. Crop prices have improved, although farmer margins remain tight. Farmers remain focused on maximizing returns per acre, supporting demand for high-performing seed, advanced genetics and differentiated technologies that can enhance yield potential and productivity. Weather, including the effects of El Niño, and trade dynamics remain sources of uncertainty and commodity-price volatility. Against that backdrop, strong global demand, improving crop economics and the growing need for agricultural output continue to support investment in productivity and technology. Our full-year outlook remains positive. Supported by the strength of our portfolio, continued technology adoption and strong year- to-date execution, the Company reaffirmed full-year 2026 guidance3, with Adjusted Pro Forma Operating EBITDA2 expected to be approximately $2.8 billion, growth of 10% at the mid-point. Adjusted Pro Forma Operating EPS2 is expected to be $2.25 to $2.35 per share, growth of 5% at the mid-point. The Company is not able to reconcile its forward-looking non-GAAP financial measures, to its most comparable U.S. GAAP financial measures, as it is unable to predict with reasonable certainty items outside of its control, such as Significant Items, without unreasonable effort. Third Quarter Conference Call The Company will host a live webcast of its third quarter 2026 earnings conference call with investors to discuss its results and outlook tomorrow, November 12, 2026, at 9:00 a.m. ET. The slide presentation that accompanies the conference call is posted on the Company’s Investor Events and Presentations page. A replay of the webcast will also be available on the Investor Events and Presentations page. About Vylor Vylor is an advanced seed and genetics company that has, for more than a century, been focused on delivering groundbreaking innovation to farmers. Anchored in the agriculture industry’s most elite germplasm and transformative biotech, Vylor leverages its scientific expertise to deliver next generation technology to help farmers around the world boost yields. With its expertise in advanced science, leading routes-to-market and an expanding licensing business, Vylor drives value and delivers growth for farmers, customers and shareholders – and in doing so, helps feed, fuel and clothe the world. More information at vylor.com. Cautionary Statement About Forward-Looking Statements This earnings release contains certain estimates and forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended, which are intended to be covered by the safe harbor provisions for forward-looking statements contained in the Private Securities Litigation Reform Act of 1995, and may be identified by their use of words like “plans,” “expects,” “will,” “assumes,” “anticipates,” “believes,” “intends,” “projects,” “targets,” “poised,” “launch,” “positioned,” “committed,” “estimates,” “outlook,” or other words of similar meaning. All statements that address expectations or projections about the future, including statements about our financial results or outlook; strategy for growth; product development; pipeline value estimates; regulatory approvals; market position; industry size and growth estimates; assumptions regarding planted acreage, commodity prices, currency rates, and market conditions; capital allocation strategy; licensing and royalty income targets; liquidity; sustainability targets and initiatives; the anticipated benefits of acquisitions, restructuring actions, or cost savings initiatives; the anticipated benefits and impacts of the spin-off; and the outcome of contingencies, such as litigation and environmental matters, are forward-looking statements. Forward-looking statements and other estimates are based on certain assumptions and expectations of future events which may not be accurate or realized. Forward-looking statements and other estimates also involve risks and uncertainties, many of which are beyond our control. While the list of factors presented below is considered representative, no such list should be considered to be a complete statement of all potential risks and uncertainties. Unlisted factors may present significant additional obstacles to the realization of forward-looking statements. Consequences of material differences in results as compared with those anticipated in the forward-looking statements could include, among other things, business disruption, operational problems, financial loss, legal liability to third parties and similar risks, any of which could have a material adverse effect on our business, results of operations and financial condition. Some of the important factors that could cause our actual results to differ materially from those projected in any such forward-looking statements include: (i) failure to obtain or maintain the necessary regulatory approvals for some of the company's products; (ii) failure to successfully develop and commercialize the company's pipeline; (iii) effect of the degree of public understanding and acceptance or perceived public acceptance of the company's biotechnology and other agricultural products; (iv) failure to comply with competition and antitrust laws; (v) effect of changes in agricultural and related policies of governments and international organizations; (vi) costs of complying with evolving regulatory requirements and the effect of actual or alleged violations of environmental laws or permit requirements; (vii) effect of climate change and unpredictable seasonal and weather factors; (viii) effect of competition in our industry; (ix) a competitor’s establishment of an intermediary platform for distribution of our products; (x) risks related to recent funding and staff reductions at U.S. government agencies; (xi) risks related to geopolitical and military conflict; (xii) effect of volatility in our input costs; (xiii) risks related to our global operations; (xiv) effect of industrial espionage and other disruptions to our supply chain, information technology or network systems; (xv) risks related to environmental, litigation, and other commitments and contingencies; (xvi) impact of our dependence on third parties with respect to certain of its seed production or licenses and commercialization; (xvii) failure of our customers to pay their debts to us, including customer financing programs; (xviii) failure to effectively manage acquisitions, divestitures, alliances, restructurings, cost savings initiatives, and other portfolio actions; (xix) risks related to our use of artificial intelligence and machine learning technologies; (xx) failure to raise capital through the capital markets or short-term borrowings on terms acceptable to us; (xxi) risks related to pandemics or epidemics; (xxii) capital markets sentiment towards sustainability matters; (xxiii) our intellectual property rights or defense against intellectual property claims asserted by others; (xxiv) effect of counterfeit products; (xxv) our dependence on intellectual property cross-license agreements; (xxvi) risks related to our common stock; and (xxvii) risks related to the spin-off, including, but not limited to, whether the objectives of the spin-off will be achieved; the terms, structure, benefits and costs of any action or transaction resulting from the spin-off; any unexpected costs or expenses resulting from the spin-off process or the spin-off itself; and the impact of litigation as a result of, or relating to, the spin-off, including, but not limited to, potential liabilities arising out of state or federal fraudulent conveyance laws and legal distribution requirements. Additionally, there may be other risks and uncertainties that Vylor is unable to currently identify or that Vylor does not currently expect to have a material impact on its business. Where, in any forward-looking statement or other estimate, an expectation or belief as to future results or events is expressed, such expectation or belief is based on the current plans and expectations of Vylor’s management and expressed in good faith and believed to have a reasonable basis, but there can be no assurance that the expectation or belief will result or be achieved or accomplished. Vylor disclaims and does not undertake any obligation to update or revise any forward-looking statement, except as required by applicable law. A detailed discussion of some of the significant risks and uncertainties which may cause results and events to differ materially from such forward-looking statements is included in the section titled “Risk Factors” in the Information Statement of Vylor Inc. dated September 24, 2026, attached as Exhibit 99.1 to Vylor Inc.’s Current Report on Form 8-K filed with the Securities and Exchange Commission (“SEC”) on September 25, 2026.

 

News Release 3Q 2026 7 Vylor Unaudited Pro Forma Financial Information and Management Adjustments On October 1, 2026, Corteva, Inc. (“Corteva”) completed its previously announced separation into two independent publicly traded companies – one comprising its Crop Protection Business (“New Corteva” or “the Crop Protection Business”) and the other comprising its Seed Business (“Vylor”, “the Company”, “our”, “we” or “the Seed Business”) - by means of a pro rata distribution of all of the then-outstanding shares of Vylor (inclusive of the Seed Business) common stock to Corteva stockholders in a transaction that is intended to be tax-free to Corteva's stockholders for U.S. federal income tax purposes (the "Vylor Separation"). Irrespective of the legal form of the Vylor Separation, for accounting and financial reporting purposes, Corteva’s Crop Protection Business is presented as being spun off from Corteva. This presentation is in accordance with U.S. GAAP and is primarily a result of, among other factors, Vylor’s relative significance to New Corteva. The following earnings release presents the pro forma results of Vylor, after giving effect to events that are (1) directly attributable including the disposition of the Crop Protection Business, the effect of our capital structure following the spin-off, the pro-rata distribution of our issued and outstanding common stock by Corteva in connection with the spin-offs, and the impact of the Separation and Distribution Agreement, Tax Matters Agreement, Employee Matters Agreement, Transition Services Agreements, Commercial Agreements, Intellectual Property Matters Agreement and other ancillary agreements between Vylor and New Corteva and the provisions contained therein; (2) factually supportable; and (3) with respect to the pro forma statements of income, expected to have a continuing impact on the consolidated results. Refer to the Information Statement of Vylor Inc. dated September 24, 2026, attached as Exhibit 99.1 to Vylor Inc.’s Current Report on Form 8-K filed with the SEC on September 25, 2026, the unaudited pro forma consolidated financial statements of Vylor attached to Vylor’s Current Report on Form 8-K filed with the SEC on November 12, 2026, as well as current and quarterly reports filed on Forms 8-K and 10-Q, which can be found on the investors section of the Vylor website, for further details on the above transactions. The pro forma financial statements were prepared in accordance with Article 11 of Regulation S-X, and are presented for informational purposes only, and do not purport to represent what the results of operations would have been had the above actually occurred on the dates indicated, nor do they purport to project the results of operations for any future period or as of any future date. This earnings release also reflects management adjustments that would not be included in the pro forma financial statements prepared in accordance with Article 11 of Regulation S-X. Historical financial statements include expense allocations for certain corporate functions performed on our behalf by Corteva, including information technology, finance, executive, human resources and legal. As a standalone public company, we expect that the costs we incur on a standalone basis for such expenses previously allocated to us by Corteva and new costs relating to our public company reporting and compliance obligations will be less than the expense allocations from Corteva within our historical financial statements. The costs of Vylor we plan to incur are based on our expected organizational structure and expected cost structure as a standalone company. In order to determine the impact of the synergies and dis-synergies, Vylor prepared a detailed assessment of personnel costs based on the estimated resources and associated costs required as a baseline to stand up as a standalone company. Vylor also includes incremental tax expense as a result of cost savings, separation costs, and additional depreciation and amortization. These adjustments reflect management’s estimates of certain incremental costs and cost savings associated with Vylor operating as an independent public company and are an adjustment to arrive at Adjusted Pro Forma Segment Operating EBITDA, Adjusted Pro Forma Operating EBITDA, Adjusted Pro Forma Operating Margin and Adjusted Pro Forma Operating Earnings per share (“EPS”). These estimates are based on assumptions management believes are reasonable as of the date of this presentation. Actual costs and savings may differ materially from these estimates, including as a result of the timing or extent to which anticipated cost savings are realized. In addition, management has also estimated one-time and nonrecurring expenses of $21 million associated with the Vylor separation expected to be incurred after the separation. These costs are not included in Adjusted Pro Forma segment Operating EBITDA, Adjusted Pro Forma Operating EBITDA, Adjusted Pro Forma Operating EBITDA Margin or Adjusted Pro Forma Operating EPS. Vylor Operating Segments Vylor consists of two operating segments: Americas, comprised of North America and Latin America, and Rest of World, comprised of Europe, Middle East, and Africa and Asia Pacific, reflecting the manner in which its chief operating decision maker (“CODM”) allocates resources and assesses performance. Research and development expense and corporate expenses are excluded from segment operating metrics as they are managed at a global level and reflected as reconciling items to consolidated Vylor Adjusted Pro Forma Operating EBITDA. See below for further detail on Vylor Adjusted Pro Forma Operating EBITDA and non-GAAP measures. The primary measure used by Vylor’s CODM for purposes of allocating resources to the segments and assessing segment performance is Adjusted Pro Forma Segment Operating EBITDA. The company defines Adjusted Pro Forma Segment Operating EBITDA as earnings (loss) (i.e., income (loss) before income taxes) before interest, depreciation, amortization, research and development expense, corporate expenses, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items and separation costs. Adjusted Pro Forma Segment Operating EBITDA also reflects reflect management’s estimates of certain incremental costs and cost savings associated with Vylor operating as an independent public company as described above. Regulation G (Non-GAAP Financial Measures) This earnings release includes information that does not conform to U.S. GAAP and are considered non-GAAP measures. These measures may include Pro Forma Organic Sales, Pro Forma Operating EBITDA, Adjusted Pro Forma Operating EBITDA, Pro Forma Operating EBITDA Margin, Adjusted Pro Forma Operating EBITDA Margin, Pro Forma Operating EPS, Adjusted Pro Forma Operating EPS, Free Cash Flow, Free Cash Flow Conversion, and Base Income Tax Rate. Management uses these measures internally for planning and forecasting, including allocating resources and evaluating incentive compensation. Management believes that these non-GAAP measures best reflect the ongoing performance of the Company during the periods presented and provide more relevant and meaningful information to investors as they provide insight with respect to ongoing operating results of the Company and a more useful comparison of year over year results. These non-GAAP measures supplement the Company’s U.S. GAAP disclosures and should not be viewed as an alternative to U.S. GAAP measures of performance. Furthermore, such non- GAAP measures may not be consistent with similar measures provided or used by other companies. This data should be read in conjunction with the Company’s Information Statement of Vylor Inc. dated September 24, 2026, attached as Exhibit 99.1 to Vylor Inc.’s Current Report on Form 8-K filed with the SEC on September 25, 2026, the unaudited pro forma consolidated financial statements of Vylor attached to Vylor’s Current Report on Form 8-K filed with the SEC on November 12, 2026, as well as our current and quarterly reports filed on Forms 8-K and 10- Q, which can be found on the “Investors” section of the Vylor website (www.vylor.com). Reconciliations of historical non-GAAP measures to U.S. GAAP are provided at the end of this presentation. Vylor does not provide reconciliations of certain forward-looking non-GAAP financial measures to their most directly comparable U.S. GAAP financial measures because Vylor is unable to predict with reasonable certainty and without unreasonable effort certain items necessary to provide such reconciliations. These items may include, among others, restructuring and separation- related charges, certain pension items, asset impairments, acquisition- or divestiture-related items, and other significant items. These items are uncertain, depend on various factors and could have a significant impact, individually or in the aggregate, on the corresponding U.S. GAAP financial measures. Pro forma Organic Sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items. Pro Forma Operating EBITDA is defined as pro forma earnings (loss) (i.e., pro forma income (loss) from continuing operations before income taxes) before interest, depreciation, amortization, non-operating benefits (costs), foreign exchange gains (losses), and net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting, excluding the impact of significant items and separation costs. Non-operating benefits (costs) consists of non-operating pension and OPEB credits (costs).Pro Forma Operating EBITDA margin is defined as pro forma Operating EBITDA as a percentage of pro forma net sales. Pro Forma Operating EPS is defined as “pro forma earnings (loss) per common share from continuing operations - diluted” excluding the after-tax impact of significant items, the after-tax impact of separation costs, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Corteva Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Although amortization of the Company’s intangible assets is excluded from these non-GAAP measures, management believes it is important for investors to understand that such intangible assets contribute to revenue generation. Amortization of intangible assets that relate to past acquisitions will recur in future periods until such intangible assets have been fully amortized. Any future acquisitions may result in amortization of additional intangible assets. Net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting represents the non-cash net gain (loss) from changes in fair value of certain undesignated foreign currency derivative contracts. Upon settlement, which is within the same calendar year of execution of the contract, the realized gain (loss) from the changes in fair value of the non-qualified foreign currency derivative contracts will be reported in the relevant non-GAAP financial measures, allowing quarterly results to reflect the economic effects of the foreign currency derivative contracts without the resulting unrealized mark to fair value volatility. Base Income Tax Rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, separation costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and non-operating (benefits) costs. Adjusted Pro Forma Operating EBITDA, Adjusted Pro Forma Operating EBITDA Margin and Adjusted Pro Forma Operating EPS represents Pro Forma Operating EBITDA, Pro Forma Operating EBITDA Margin, and Pro Forma Operating EPS further adjusted to reflect management’s estimates of certain incremental cost savings associated with operating Vylor as an independent public company that are not reflected in the Pro Forma Operating EBITDA, Pro Forma Operating EBITDA Margin, and Pro Forma Operating EPS, respectively. Management believes these measures provide useful supplemental information regarding the expected cost structure of Vylor as an independent public company. The management adjustments are based on estimates and assumptions and actual costs and savings may differ materially from those reflected in the adjustments.

 

News Release 3Q 2026 8 The Company also uses Free Cash Flow and Free Cash Flow Conversion as non-GAAP measures to evaluate and discuss its liquidity position and ability to generate cash. Free Cash Flow is defined as cash provided by (used for) operating activities – continuing operations, less capital expenditures. Free Cash Flow Conversion is defined as Free Cash Flow divided by Adjusted Pro Forma Operating EBITDA. We believe that Free Cash Flow and Free Cash Flow Conversion provide investors with meaningful information regarding the Company’s ongoing ability to generate cash through core operations, and our ability to service our indebtedness, pay dividends (when declared), make share repurchases, and meet our ongoing cash needs for our operations. Vylor is not able to reconcile its forward-looking Free Cash Flow Conversion non-GAAP financial measure to its most comparable U.S. GAAP financial measure, as it is unable to predict with reasonable certainty Operating EBITDA due to items outside of the company’s control, which includes the same Significant Items noted above, without unreasonable effort. Projected Financial Information This presentation contains financial forecasts, which were prepared in good faith by Vylor on a basis believed to be reasonable. Certain financial measures and targets in this presentation are non-GAAP measures, as described in the Regulation G disclaimer included elsewhere in this presentation. The pro forma financial information has been prepared in accordance with Article 11 of Regulation S-X. The financial projections in this presentation have not been audited or reviewed by Vylor’s independent auditors. These projections are for illustrative purposes only and should not be relied upon as being necessarily indicative of future results. See the Forward-Looking Statements disclaimer included elsewhere in this presentation for a discussion of risks and uncertainties that may cause actual results to differ materially. ® TM Vylor and its affiliated companies. 11/11/2026 Media Contact Derek Burleson +1 479-651-0275 derek.burleson@vylor.com Investor Contact Kim Booth +1 302-485-3190 kimberly.a.booth@vylor.com

 

A-1
Vylor Inc.
Pro Forma Consolidated Statements of Operations 1
(Dollars in millions, except per share amounts)
Three Months Ended September 30,Nine Months Ended
September 30,
2026202520262025
Net sales$938 $944 $8,531 $8,235 
Cost of goods sold598 606 3,601 3,698 
Research and development expense268 234 773 720 
Selling, general and administrative expenses416 401 1,775 1,681 
Amortization of intangibles120 122 396 368 
Restructuring and asset related charges - net(1)— 31 3 
Separation costs99 7 228 7 
Other income (expense) - net(10)(67)(231)(66)
Interest expense34 35 102 139 
Income (loss) from continuing operations before income taxes(606)(528)1,394 1,553 
Provision for (benefit from) income taxes(126)(137)387 324 
Income (loss) from continuing operations after income taxes(480)(391)1,007 1,229 
Net income (loss) from continuing operations attributable to noncontrolling interests— — 2 1 
Net income (loss) from continuing operations attributable to Vylor$(480)$(391)$1,005 $1,228 
Basic earnings (loss) per share of common stock:
Basic earnings (loss) per share of common stock $(0.72)$(0.58)$1.50 $1.80 
Diluted earnings (loss) per share of common stock:
Diluted earnings (loss) per share of common stock $(0.72)$(0.58)$1.50 $1.80 
Average number of shares outstanding used in earnings (loss) per share (EPS) calculation (in millions)
  Basic667.8678.7669.5681.7
  Diluted667.8678.7670.7683.1

1.See Article 11 Unaudited Pro Forma Consolidated Statements of Operations on Form 8-K filed with the SEC on November 12, 2026.

A-2
Vylor Inc.
Pro Forma Consolidated Balance Sheet 1
(Dollars in millions, except share amounts)
September 30, 2026
Assets
Current assets
Cash and cash equivalents$1,312 
Marketable securities— 
Accounts and notes receivable - net3,356 
Inventories2,817 
Other current assets224 
Total current assets7,709 
Investment in nonconsolidated affiliates79 
Property, plant and equipment4,634 
Less: Accumulated depreciation2,180 
Net property, plant and equipment2,454 
Goodwill5,264 
Other intangible assets6,867 
Deferred income taxes49 
Other assets772 
Total Assets$23,194 
Liabilities and Equity
Current liabilities
Short-term borrowings$3,144 
Accounts payable1,910 
Income taxes payable52 
Deferred revenue373 
Accrued and other current liabilities1,109 
Total current liabilities6,588 
Long-term debt2,510 
Other noncurrent liabilities
Deferred income tax liabilities919 
Pension and other post-employment benefits89 
Other noncurrent obligations509 
Total noncurrent liabilities4,027 
Commitments and contingent liabilities
Stockholders' equity
Common stock, $0.01 par value; 1,666,667,000 shares authorized; issued at September 30, 2026 - 667,304,0007 
Additional paid-in capital14,042 
Retained earnings (accumulated deficit)— 
Accumulated other comprehensive income (loss)(1,476)
Total Vylor stockholders' equity12,573 
Noncontrolling interests6 
Total equity12,579 
Total Liabilities and Equity$23,194 
1.See Article 11 Unaudited Pro Forma Consolidated Balance Sheet on Form 8-K filed with the SEC on November 12, 2026.

A-3
Vylor Inc.
Pro Forma Consolidated Segment Information
(Dollars in millions, except share amounts)

Three Months Ended September 30,Nine Months Ended
September 30,
SEGMENT PRO FORMA NET SALES - AMERICAS 1
2026202520262025
    Corn$432 $382 $4,635 $4,428 
    Soybean128 $172 1,764 1,755 
    Other oilseeds14 $16 203 186 
    Other39 $24 158 161 
Americas$613 $594 $6,760 $6,530 
Three Months Ended September 30,Nine Months Ended
September 30,
SEGMENT PRO FORMA NET SALES - REST OF WORLD 1
2026202520262025
Corn$175 $204 $1,213 $1,188 
Soybean5 7 32 33 
Other oilseeds136 119 418 364 
Other9 20 108 120 
Rest of World$325 $350 $1,771 $1,705 
Three Months Ended September 30,Nine Months Ended
September 30,
GEOGRAPHIC PRO FORMA NET SALES 2026202520262025
North America 2
$226 $203 $5,989 $5,800 
Latin America387 391 771 730 
Americas613 594 6,760 6,530 
EMEA 3
267 262 1,468 1,370 
Asia Pacific58 88 303 335 
Rest of World$325 $350 $1,771 $1,705 
Pro Forma Net Sales$938 $944 $8,531 $8,235 

1.See page 7 for definition of Vylor operating segments.
2.North America is comprised of the United States and Canada.
3.EMEA is comprised of Europe, the Middle East, and Africa.




A-4
Vylor Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except share amounts)
Three Months Ended September 30,Nine Months Ended
September 30,
20262026
Pro Forma Net Sales (GAAP)$938 $8,531 
Add: Impacts from Currency and Portfolio / Other(27)(119)
Pro Forma Organic Sales (Non-GAAP)$911 $8,412 
Three Months Ended September 30,Nine Months Ended
September 30,
PRO FORMA AND ADJUSTED PRO FORMA OPERATING EBITDA2026202520262025
Americas$(84)$(104)$2,880 $2,597 
Rest of World92 134 555 568 
Research and development 1
(250)(209)(705)(645)
Corporate expenses 1
(27)(23)(67)(59)
Adjusted Pro Forma Operating EBITDA (Non-GAAP)$(269)$(202)$2,663 $2,461 
Less: Management adjustments, excluding depreciation 2
$(10)$(20)$(50)$(60)
Pro Forma Operating EBITDA (Non-GAAP)$(279)$(222)$2,613 $2,401 
RECONCILIATION OF PRO FORMA INCOME (LOSS) FROM CONTINUING OPERATIONS TO PRO FORMA OPERATING EBITDA AND ADJUSTED PRO FORMA OPERATING EBITDAThree Months Ended September 30,Nine Months Ended
September 30,
2026202520262025
Pro Forma Income (loss) from continuing operations after income taxes (GAAP)$(480)$(391)$1,007 $1,229 
Provision for (benefit from) income taxes on continuing operations(126)(137)387 324 
Pro Forma Income (loss) from continuing operations before income taxes (GAAP)(606)(528)1,394 1,553 
Depreciation and amortization200 195 627 587 
Interest income(13)(12)(33)(33)
Interest expense34 35 102 139 
Exchange (gains) losses - net 3
10 81 235 106 
Non-operating (benefits) costs - net 4
(1)1 15 3 
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges(1)— 14 — 
Significant items (benefit) charge 5
(1)(1)31 39 
Separation costs99 7 228 7 
Pro Forma Operating EBITDA (Non-GAAP)$(279)$(222)$2,613 $2,401 
Management adjustments, excluding depreciation 2
$10 $20 $50 $60 
Adjusted Pro Forma Operating EBITDA (Non-GAAP)$(269)$(202)$2,663 $2,461 

1.Research and development expense and corporate expenses are presented net of management adjustments. See footnote 3 for further discussion of management adjustments.
2.Management adjustments reflects management’s estimates of certain incremental costs and cost savings associated with Vylor operating as an independent public company that are not reflected in Pro Forma Operating EBITDA. Management adjustments to arrive at Adjusted Pro Forma Operating EBITDA excludes additional depreciation expense of $3 million and $12 million for the three and nine months ended September 30, 2026, respectively and $4 million and $12 million for the three and nine months ended September 30, 2025, respectively.
3.See page A-13 for pre-tax and after tax impacts of exchange (gains) losses.
4.Non-operating (benefits) costs consists of non-operating pension and other post-employment benefit (OPEB) (credits) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as a pre-tax income or expense.
5.See page A-9 for pre-tax and after tax impacts of significant items.


A-5
Vylor Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except share amounts)
PRICE - VOLUME - CURRENCY ANALYSIS
REGION
Q3 2026 vs. Q3 2025Percent Change Due To:
Pro Forma Net Sales Change
(GAAP)
Pro Forma Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$23 11 %$25 12 %16 %(4)%(1)%— %
Latin America(4)(1)%(21)(5)%2 %(7)%4 %— %
Americas19 3 %4 1 %7 %(6)%2 %— %
EMEA5 2 %(11)(4)%5 %(9)%6 %— %
Asia Pacific(30)(34)%(26)(30)%5 %(35)%(4)%— %
Rest of World(25)(7)%(37)(11)%5 %(16)%4 %— %
Total$(6)(1)%$(33)(3)%6 %(9)%2 %— %
1.Pro Forma Organic Sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items.


A-6
Vylor Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except share amounts)
AMERICAS
Q3 2026 vs. Q3 2025Percent Change Due To:
Pro Forma Net Sales Change
(GAAP)
Pro Forma Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn$50 13 %$35 9 %5 %4 %4 %— %
Soybean(44)(26)%(44)(26)%10 %(36)%— %— %
Other oilseeds(2)(13)%(2)(13)%11 %(24)%— %— %
Other15 63 %15 63 %9 %54 %— %— %
Total $19 3 %$4 1 %7 %(6)%2 %— %
REST OF WORLD
Q3 2026 vs. Q3 2025Percent Change Due To:
Pro Forma Net Sales Change
(GAAP)
Pro Forma Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn$(29)(14)%$(46)(23)%4 %(27)%9 %— %
Soybean(2)(29)%(2)(29)%15 %(44)%— %— %
Other oilseeds17 14 %22 18 %6 %12 %(4)%— %
Other(11)(55)%(11)(55)%2 %(57)%— %— %
Total$(25)(7)%$(37)(11)%5 %(16)%4 %— %
TOTAL
Q3 2026 vs. Q3 2025Percent Change Due To:
Pro Forma Net Sales Change
(GAAP)
Pro Forma Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn$21 4 %$(11)(2)%5 %(7)%6 %— %
Soybean(46)(26)%(46)(26)%10 %(36)%— %— %
Other oilseeds15 11 %20 15 %7 %8 %(4)%— %
Other4 9 %4 9 %6 %3 %— %— %
Total$(6)(1)%$(33)(3)%6 %(9)%2 %— %

1.Pro Forma Organic Sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items.

A-7
Vylor Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except share amounts)
PRICE - VOLUME - CURRENCY ANALYSIS
REGION
Nine Months 2026 vs. Nine Months 2025Percent Change Due To:
Pro Forma Net Sales Change
(GAAP)
Pro Forma Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
North America$189 3 %$180 3 %2 %1 %— %— %
Latin America41 6 %(13)(2)%5 %(7)%8 %— %
Americas230 4 %167 3 %3 %— %1 %— %
EMEA98 7 %21 2 %4 %(2)%5 %— %
Asia Pacific(32)(10)%(11)(3)%7 %(10)%(7)%— %
Rest of World66 4 %10 1 %5 %(4)%3 %— %
Total$296 4 %$177 2 %3 %(1)%2 %— %
1.Pro Forma Organic Sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items.

A-8
Vylor Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except share amounts)
AMERICAS
Nine Months 2026 vs. Nine Months 2025Percent Change Due To:
Pro Forma Net Sales Change
(GAAP)
Pro Forma Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn$207 5 %$154 3 %4 %(1)%2 %— %
Soybean9 1 %6 — %— %— %1 %— %
Other oilseeds17 9 %14 8 %8 %— %1 %— %
Other(3)(2)%(7)(4)%(6)%2 %2 %— %
Total $230 4 %$167 3 %3 %— %1 %— %
REST OF WORLD
Nine Months 2026 vs. Nine Months 2025Percent Change Due To:
Pro Forma Net Sales Change
(GAAP)
Pro Forma Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn$25 2 %$(34)(3)%4 %(7)%5 %— %
Soybean(1)(3)%(4)(12)%5 %(17)%9 %— %
Other oilseeds54 15 %53 15 %7 %8 %— %— %
Other(12)(10)%(5)(4)%5 %(9)%(6)%— %
Total$66 4 %$10 1 %5 %(4)%3 %— %
TOTAL
Nine Months 2026 vs. Nine Months 2025Percent Change Due To:
Pro Forma Net Sales Change
(GAAP)
Pro Forma Organic Change 1
(Non-GAAP)
Price &Portfolio /
$%$%Product MixVolumeCurrencyOther
Corn$232 4 %$120 2 %4 %(2)%2 %— %
Soybean8 — %2 — %— %— %— %— %
Other oilseeds71 13 %67 12 %7 %5 %1 %— %
Other(15)(5)%(12)(4)%(1)%(3)%(1)%— %
Total$296 4 %$177 2 %3 %(1)%2 %— %

1.Pro Forma Organic Sales is defined as price and volume and excludes currency and portfolio and other impacts, including significant items.

A-9
Vylor Inc.
Significant Items
(Dollars in millions, except per share amounts)


SIGNIFICANT ITEMS BY SEGMENT (PRE-TAX)
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Americas$— $— $— $(40)
Rest of World— 1 — — 
Corporate1 — (31)1 
Total significant items before income taxes$1 $1 $(31)$(39)
SIGNIFICANT ITEMS - PRE-TAX, AFTER TAX, AND EPS IMPACTS
Pre-tax
After tax 6
($ Per Share)
202620252026202520262025
1st Quarter
Restructuring and asset related charges - net 1
$(29)$(2)$(23)$(2)$(0.03)$— 
   AltEn facility remediation charges 2
— (37)— (27)— (0.04)
   Income tax items 3
— — — 55 — 0.08 
1st Quarter – Total
$(29)$(39)$(23)$26 $(0.03)$0.04 
2nd Quarter
Restructuring and asset related charges - net 1
$(3)$(1)$(2)$(1)$— $— 
2nd Quarter – Total
$(3)$(1)$(2)$(1)$— $— 
3rd Quarter
Restructuring and asset related charges, net 1
$1 $1 $1 $1 $— $— 
Income tax items 4
— — (16)— (0.02)— 
3rd Quarter – Total
$1 $1 $(15)$1 $(0.02)$— 
Year-to-Date Total 5
$(31)$(39)$(40)$26 $(0.06)$0.04 

1.Third, second and first quarter 2026 include restructuring and asset related benefits (charges) of $1, $(3) and $(29), respectively. The third, second and first quarter 2026 charges primarily relate to committed restructuring actions.
Third, second and first quarter 2025 include restructuring and asset related benefits (charges) of $1, $(1) and $(2), respectively. The charges primarily relate to committed restructuring actions.

2.First quarter 2025 includes a charge relating to the increase in the remediation accrual at the AltEn facility consisting of Vylor's estimated voluntary contribution to the solid waste and wastewater remedial action plans.

3.First quarter 2025 reflects a deferred tax benefit of $55 associated with a change in a legal entity's U.S. tax characterization.

4.The tax only significant item for the three and nine months ended September 30, 2026 was driven by legal entity restructuring activities associated with the Vylor Separation.


5.Earnings per share for the year may not equal the sum of quarterly earnings per share due to the changes in average share calculations.

6.Unless specifically addressed above, the income tax effect on significant items was calculated based upon the enacted tax laws and statutory income tax rates applicable in the tax jurisdiction(s) of the underlying non-GAAP adjustment.

A-10
Vylor Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions, except per share amounts)
Pro Forma and Adjusted Pro Forma Operating Earnings (Loss) Per Share (Non-GAAP)
Pro Forma Operating Earnings (Loss) per share ("EPS") is defined as earnings (loss) per common share from continuing operations – diluted, excluding the after-tax impact of significant items, the after-tax impact of separation costs, the after-tax impact of non-operating benefits (costs), the after-tax impact of amortization expense associated with intangible assets existing as of the Corteva Separation from DowDuPont, and the after-tax impact of net unrealized gain or loss from mark-to-market activity for certain foreign currency derivative instruments that do not qualify for hedge accounting. Adjusted Pro Forma Operating EPS is defined as Pro Forma Operating EPS adjusted for after-tax impact of management adjustments.
Three Months Ended
September 30,
2026202520262025
$$EPS (diluted)EPS (diluted)
Pro forma income (loss) from continuing operations attributable to Vylor (GAAP) 1
$(480)$(391)$(0.72)$(0.58)
Non-operating costs (benefits), after tax 2
(1)1 — — 
Amortization of intangibles (existing as of Corteva Separation), after tax90 92 0.14 0.14 
Mark-to-market losses (gains) on certain foreign currency contracts not designated as hedges, after tax(1)— — — 
Significant items charge (benefit), after tax15 (1)0.02 — 
Separation costs, after tax89 7 0.13 0.01 
Pro Forma Operating Earnings (Loss) (Non-GAAP) 3
$(288)$(292)$(0.43)$(0.43)
Management adjustments, after tax 4
$5 $12 $0.01 $0.02 
Adjusted Pro Forma Operating Earnings (Loss) (Non-GAAP)$(283)$(280)$(0.42)$(0.41)

Nine Months Ended
September 30,
2026202520262025
$$EPS (diluted)EPS (diluted)
Pro forma income (loss) from continuing operations attributable to Vylor (GAAP) 1
$1,005 $1,228 $1.50 $1.80 
Non-operating costs (benefits), after tax 2
12 2 0.02 — 
Amortization of intangibles (existing as of Corteva Separation), after tax299 279 0.45 0.41 
Mark-to-market losses (gains) on certain foreign currency contracts not designated as hedges, after tax10 — 0.01 — 
Significant items charge (benefit), after tax40 (26)0.06 (0.04)
Separation costs, after tax194 7 0.29 0.01 
Pro Forma Operating Earnings (Loss) (Non-GAAP) 3
$1,560 $1,490 $2.33 $2.18 
Management adjustments, after tax 4
$29 $36 $0.04 $0.05 
Adjusted Pro Forma Operating Earnings (Loss) (Non-GAAP)$1,589 $1,526 $2.37 $2.23 

1.See Unaudited Article 11 Pro Forma Consolidated Statements of Operations on Form 8-K filed with the SEC on November 12, 2026.
2.Non-operating costs (benefits) consists of non-operating pension and other post-employment benefit (OPEB) (credits) costs, tax indemnification adjustments and environmental remediation and legal costs associated with legacy businesses and sites. Tax indemnification adjustments relate to changes in indemnification balances, as a result of the application of the terms of the Tax Matters Agreement, between Corteva and Dow and/or DuPont that are recorded by the company as a pre-tax income or expense.
3.See page A-11 for the Non-GAAP reconciliation of Pro Forma Operating EBITDA to Operating Earnings (Loss) per share.
4.Management adjustments reflects management’s estimates of certain incremental costs and cost savings associated with Vylor operating as an independent public company that are not reflected in Pro Forma Operating Earnings.



A-11
Vylor Inc.
Pro Forma Operating EBITDA to Adjusted Operating EPS
(Dollars in millions, except per share amounts)

Pro Forma Operating EBITDA to Adjusted Operating EPS
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Pro Forma Operating EBITDA (Non-GAAP) 1
$(279)$(222)$2,613 $2,401 
Depreciation(80)(73)(231)(219)
Amortization of intangibles (post Corteva Separation)(2)(1)(5)(3)
Interest income13 12 33 33 
Interest expense(34)(35)(102)(139)
 (Provision for) benefit from income taxes on continuing operations before significant items, separation costs, non-operating benefits (costs), amortization of intangibles (existing as of Corteva Separation), mark-to-market gains (losses) on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP) 1
99 91 (564)(479)
Base income tax rate from continuing operations (Non-GAAP) 1
25.9 %28.5 %24.4 %23.1 %
Exchange gains (losses), after tax 2
(5)(64)(182)(103)
Net (income) loss attributable to non-controlling interests— — (2)(1)
Pro Forma Operating Earnings (Loss) (Non-GAAP) 1
$(288)$(292)$1,560 $1,490 
Management adjustments, after tax3
5 12 29 36 
Adjusted Pro Forma Operating Earnings (Loss) (Non-GAAP)(283)(280)1,589 1,526 
Diluted Shares (in millions)667.8 678.7 670.7 683.1 
Pro Forma Operating EPS (Non-GAAP) 1
$(0.43)$(0.43)$2.33 $2.18 
Adjusted Pro Forma Operating EPS (Non-GAAP) 1
$(0.42)$(0.41)$2.37 $2.23 

1.     See pages A-4 through A-8, A-10 and A-12 for Non-GAAP reconciliations.
2.     See page A-13 for pre-tax and after tax impacts of exchange gains (losses).
3. Management adjustments reflects management’s estimates of certain incremental costs and cost savings associated with Vylor operating as an independent public company that are not reflected in Pro Forma Operating Earnings (Loss).


A-12
Vylor Inc.
Reconciliation of Non-GAAP Measures
(Dollars in millions)

Reconciliation of Base Income Tax Rate to Effective Income Tax Rate
Base income tax rate is defined as the effective income tax rate less the effect of exchange gains (losses), significant items, separation costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and non-operating (benefits) costs.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Pro forma income before income taxes (GAAP)
$(606)$(528)$1,394 $1,553 
Add: Significant items (benefit) charge 1
(1)(1)31 39 
Separation costs99 7 228 7 
Non-operating (benefits) costs(1)1 15 3 
Amortization of intangibles (existing as of Corteva Separation)118 121 391 365 
Mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges(1)— 14 — 
Less: Exchange gains (losses) 2
(10)(81)(235)(106)
Pro forma income (loss) from continuing operations before income taxes, significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP)
$(382)$(319)$2,308 $2,073 
Provision for (benefit from) income taxes on continuing operations (GAAP)
$(126)$(137)$387 $324 
Add: Tax (expenses) benefits on significant items (benefit) charge 1
(16)— (9)65 
Tax benefits on separation costs10 — 34 — 
Tax (expenses) benefits on non-operating (benefits) costs— — 3 1 
Tax benefits on amortization of intangibles (existing as of Corteva Separation)28 29 92 86 
 Tax (expenses) benefits on mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges— — 4 — 
Tax (expenses) benefits on exchange gains (losses) 2
5 17 53 3 
Provision for (benefit from) income taxes on continuing operations before significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges, and exchange gains (losses) (Non-GAAP)
$(99)$(91)$564 $479 
Effective income tax rate (GAAP)
20.8 %25.9 %27.8 %20.9 %
Significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), and mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges effect5.7 %1.1 %(3.1)%3.3 %
Tax rate from continuing operations before significant items, separation costs, non-operating (benefits) costs, amortization of intangibles (existing as of Corteva Separation), and mark-to-market (gains) losses on certain foreign currency contracts not designated as hedges26.5 %27.0 %24.7 %24.2 %
Exchange gains (losses), net effect 2
(0.6)%1.5 %(0.3)%(1.1)%
Base income tax rate from continuing operations (Non-GAAP)
25.9 %28.5 %24.4 %23.1 %
Management adjustments, net effect 3
— %0.2 %— %0.1 %
Base income tax rate from continuing operations, post-management adjustment (Non-GAAP)
25.9 %28.7 %24.4 %23.2 %

1.See page A-9 for further detail on the significant items table.
2.See page A-13 for further details of exchange gains (losses).
3.Management adjustments reflects management’s estimates of certain incremental costs and cost savings associated with Vylor operating as an independent public company. Management adjustments, net effect includes tax provisions within management adjustments of $2 million and $9 million for the three and nine months ended September 30, 2026, respectively and $4 million and $7 million for the three and nine months ended September 30, 2025, respectively.

A-13
Vylor Inc.
(Dollars in millions, except per share amounts)

Pro Forma Exchange Gains/Losses
The Company routinely uses foreign currency exchange contracts to offset its net exposures, by currency, related to the foreign currency-denominated monetary assets and liabilities. The objective of this program is to maintain an approximately balanced position in foreign currencies in order to minimize, on an after-tax basis, the effects of exchange rate changes on net monetary asset positions. The hedging program gains (losses) are largely taxable (tax deductible) in the United States (U.S.), whereas the offsetting exchange gains (losses) on the remeasurement of the net monetary asset positions are often not taxable (tax deductible) in their local jurisdictions. The net pre-tax exchange gains (losses) are recorded in other income (expense) - net and the related tax impact is recorded in provision for (benefit from) income taxes on continuing operations in the Consolidated Statements of Operations.
Three Months Ended
September 30,		Nine Months Ended
September 30,
2026202520262025
Subsidiary Monetary Position Gain (Loss)
Pre-tax exchange gain (loss)$(1)$(11)$(8)$(87)
Local tax (expenses) benefits2 — (1)(1)
Net after-tax impact from subsidiary exchange gain (loss)$1 $(11)$(9)$(88)
Hedging Program Gain (Loss)
Pre-tax exchange gain (loss)$(9)$(70)$(227)$(19)
Tax (expenses) benefits3 17 54 4 
Net after-tax impact from hedging program exchange gain (loss)$(6)$(53)$(173)$(15)
Total Exchange Gain (Loss) 1
Pre-tax exchange gain (loss)$(10)$(81)$(235)$(106)
Tax (expenses) benefits5 17 53 3 
Net after-tax exchange gain (loss)$(5)$(64)$(182)$(103)
1. The "Total Exchange Gain (Loss)" is the sum of the "Subsidiary Monetary Position Gain (Loss)" and the "Hedging Program Gain (Loss)."

A-14
Corteva, Inc.
Consolidated Balance Sheets
(Dollars in millions, except share amounts)
September 30, 2026December 31, 2025September 30, 2025
Assets
Current assets
Cash and cash equivalents$3,932 $4,521 $2,509 
Marketable securities1 9 77 
Accounts and notes receivable - net7,491 6,371 7,784 
Inventories5,482 5,667 5,310 
Other current assets980 767 758 
Total current assets$17,886 $17,335 $16,438 
Investment in nonconsolidated affiliates147 160 141 
Property, plant and equipment9,840 9,551 9,633 
Less: Accumulated depreciation5,657 5,331 5,431 
Net property, plant and equipment4,183 4,220 4,202 
Goodwill10,416 10,465 10,512 
Other intangible assets7,845 8,301 8,428 
Deferred income taxes335 320 434 
Other assets2,219 2,044 2,043 
Total Assets$43,031 $42,845 $42,198 
Liabilities and Equity
Current liabilities
Short-term borrowings$3,988 $894 $2,685 
Accounts payable4,431 4,398 4,337 
Income taxes payable146 155 254 
Deferred revenue440 3,579 483 
Accrued and other current liabilities2,445 3,099 2,661 
Total current liabilities11,450 12,125 10,420 
Long-term debt3,458 1,686 1,688 
Other noncurrent liabilities
Deferred income tax liabilities567 251 373 
Pension and other post-employment benefits877 2,434 2,215 
Other noncurrent obligations1,942 1,963 2,041 
Total noncurrent liabilities6,844 6,334 6,317 
Commitments and contingent liabilities
Stockholders' equity
Common stock, $0.01 par value; 1,666,666,667 shares authorized; issued at September 30, 2026 - 667,304,000; December 31, 2025 - 672,163,000; and September 30, 2025 - 676,755,0007 7 7 
Additional paid-in capital26,934 27,001 27,039 
Retained earnings (accumulated deficit)533 (67)834 
Accumulated other comprehensive income (loss)(2,981)(2,797)(2,661)
Total Corteva stockholders' equity24,493 24,144 25,219 
Noncontrolling interests244 242 242 
Total equity24,737 24,386 25,461 
Total Liabilities and Equity$43,031 $42,845 $42,198 



A-15
Corteva, Inc.
Consolidated Statements of Operations
(Dollars in millions, except per share amounts)
Three Months Ended September 30,
Nine Months Ended
September 30,
2026202520262025
Net sales$2,458 $2,618 $13,742 $13,491 
Cost of goods sold$1,534 1,644 $6,624 6,918 
Research and development expense$397 351 $1,126 1,061 
Selling, general and administrative expenses$732 725 $2,773 2,632 
Amortization of intangibles$159 162 $513 485 
Restructuring and asset related charges - net$17 30 $158 131 
Separation costs$99 7 $230 7 
Other income (expense) - net$(34)(23)$(266)95 
Interest expense$75 46 $158 134 
Income (loss) from continuing operations before income taxes$(589)(370)1,894 2,218 
Provision for (benefit from) income taxes on continuing operations$(62)(62)479 477 
Income (loss) from continuing operations after income taxes$(527)(308)1,415 1,741 
Income (loss) from discontinued operations after income taxes$(41)(10)(95)(87)
Net income (loss)$(568)(318)1,320 1,654 
Net income (loss) attributable to noncontrolling interests$2 2 9 8 
Net income (loss) attributable to Corteva$(570)(320)$1,311 1,646 
Basic earnings (loss) per share of common stock:
Basic earnings (loss) per share of common stock from continuing operations$(0.79)$(0.46)$2.10 $2.54 
Basic earnings (loss) per share of common stock from discontinued operations(0.06)(0.01)(0.14)(0.13)
Basic earnings (loss) per share of common stock$(0.85)$(0.47)$1.96 $2.41 
Diluted earnings (loss) per share of common stock:
Diluted earnings (loss) per share of common stock from continuing operations$(0.79)$(0.46)$2.10 $2.54 
Diluted earnings (loss) per share of common stock from discontinued operations(0.06)(0.01)(0.14)(0.13)
Diluted earnings (loss) per share of common stock$(0.85)$(0.47)$1.96 $2.41 
Average number of shares outstanding used in earnings (loss) per share (EPS) calculation (in millions)
  Basic667.8 678.7 $669.5 681.7 
  Diluted667.8 678.7 670.7 683.1 


Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

6 documents

Press Releases

Other Documents

Keep reading

More on VYLR

All VYLR news

Trending in the feed

NVDA
NVIDIA Announces CEO Transition Open the live feed